[On the treatment of chronic polyarthritis with cytostatic drugs. II. Oral application of Trenimon. Clinical and serological studies].
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000008:administration & dosage*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D002097:C-Reactive Protein / Q000097:blood; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011033:Podophyllin / Q000008:administration & dosage; D012217:Rheumatoid Factor / Q000097:blood; D014228:Triaziquone / Q000008:administration & dosage* / Q000009:adverse effects
D000477:Alkylating Agents; D011033:Podophyllin; D002097:C-Reactive Protein; D012217:Rheumatoid Factor; D014228:Triaziquone
Zur Behandlung der chronischen Polyarthritis mit Zytostatika. II. Orale Applikation von Trenimon. Klinische und serologische Studien.